Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AX Other antivirals
J05AX26 Amenamevir
D10564 Amenamevir (JAN/INN) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
62 Chemotherapeutics
625 Antivirals
6250 Antivirals
D10564 Amenamevir (JAN/INN)
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
D10564 Amenamevir
Metabolizing enzyme inducer
DG02891 CYP2B6 inducer
D10564 Amenamevir
DG02853 CYP3A/CYP3A4 inducer
D10564 Amenamevir
Antimicrobials [BR:br08307]
Antivirals
Genome replication inhibitor
Other inhibitor
D10564 Amenamevir (JAN/INN) <JP>
Antimicrobials abbreviations [BR:br08327]
Antivirals
Genome replication inhibitor
Other inhibitor
D10564 Amenamevir (JAN/INN)
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D10564
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D10564
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D10564